DLB
Dolby Laboratories, Inc.
Set alert
- YTD
- -3.47%
- 1 year
- -5.59%
- Open
- 63.07
- Prev close
- 62.91
- Mkt cap
- 5.81B
- Vol
- 688.77K
- Avg vol
- 866.01K
- EPS
- 2.35
- P/E
- 26.38
- Div yield
- 2.29%
More statistics
- Low
- 61.54
- High
- 63.41
- Forward P/E
- 13.54
- Beta
- 0.78
- Short ratio
- 7.01
- Inst. own
- 107.47%
- Dividend
- 1.44
- Ex-div date
- Aug 10, 2026
- Earnings
- Nov 17, 2026
- 50-d avg
- 60.82
- 200-d avg
- 59.28
- 1y target
- 79.00
Key statistics
- Market cap
- 5.81B
- Enterprise value
- 5.28B
- Trailing P/E
- 26.39
- Forward P/E
- 13.54
- PEG ratio
- 1.29
- Price / sales
- 4.29
- Price / book
- 2.25
- EPS (TTM)
- 2.35
- Beta
- 0.78
- Dividend yield
- 2.29%
- Payout ratio
- 60.00%
- Profit margin
- 16.70%
- Revenue (TTM)
- 1.35B
- Revenue growth
- -3.30%
- Free cash flow
- 331.85M
- Total cash
- 670.05M
- Total debt
- 47.45M
- Return on equity
- 8.76%
- Shares outstanding
- 59.42M
- Short % of float
- 13.50%
- 50-day average
- 60.82
- 200-day average
- 59.28
Analyst view
Consensus: buy
- Target (low)
- 62.00
- Target (mean)
- 79.00
- Target (high)
- 90.00
- Strong buy1
- Buy2
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 17, 2026
Expected Nov 17, 2026. Consensus EPS estimate 1.20.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 17, 2026 | Sep 26, 2026 | 1.19 | — | — | — |
| Jul 30, 2026 | Jun 26, 2026 | 0.671 | 0.69 | +0.02 | +2.83% |
| Apr 30, 2026 | Mar 27, 2026 | 1.31 | 1.37 | +0.06 | +4.58% |
| Jan 29, 2026 | Dec 26, 2025 | 0.993 | 1.06 | +0.07 | +6.75% |
| Nov 18, 2025 | Sep 26, 2025 | 0.699 | 0.99 | +0.29 | +41.63% |
| Jul 31, 2025 | Jun 27, 2025 | 0.72 | 0.78 | +0.06 | +8.33% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 28, 2026 | Rosenblatt | main | Buy | Buy |
| Jul 31, 2026 | Rosenblatt | main | Buy | Buy |
| Jun 15, 2026 | Barrington Research | main | Outperform | Outperform |
| Jun 11, 2026 | Rosenblatt | main | Buy | Buy |
| Apr 27, 2026 | Barrington Research | main | Outperform | Outperform |
| Jan 30, 2026 | Barrington Research | main | Outperform | Outperform |
About Dolby Laboratories, Inc.
Dolby Laboratories, Inc. engages in the design and manufacture of audio, imaging, accessibility, and other hardware and software solutions for television, broadcast, and live entertainment industries in the United States and internationally. The company develops and licenses its audio technologies, such as AAC, HE-AAC, and extended HE-AAC, a digital audio codec solution; AVC, a digital video codec used in STBs, mobile devices, cameras, and broadcast television services and other products; and Dolby Atmos and Dolby Vision include encoding technologies that artists use to create more compelling and immersive audio and video experiences. It also provides DD+, an advanced surround sound audio codec technology; Dolby AC-4, an audio codec that uses cutting edge compression; and HEVC, a digital video codec that compresses video. In addition, the company offers Dolby Cinemas, a premium large format cinemas that deliver a Dolby branded premium cinema offering with Dolby Vision, Dolby Atmos, and a Dolby theater design; Dolby.io, a SaaS product of immersive, interactive, and social experiences with real-time engagement for live events, especially sports; and digital cinema servers, cinema processors, amplifiers, loudspeakers, and audio and imaging hardware and software products for the cinema, television, broadcast, communication, and entertainment industries. Further, it provides various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. It serves film studios, content creators, post-production facilities, and broadcasters. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.
- Sector
- Industrials
- Industry
- Specialty Business Services
- Country
- United States
- Website
- dolby.com
News
- CervoMed Announces Publication of Two Peer-Reviewed Research Articles Supporting Neflamapimod as a Potential Treatment for Dementia with Lewy Bodies (DLB)
- Dolby Laboratories Announces Conference Call and Webcast for Q4 Fiscal 2026 Financial Results
- Dolby Laboratories (NYSE:DLB) & Palo Alto Networks (NASDAQ:PANW) Financial Contrast
- Analyzing Dolby Laboratories (NYSE:DLB) & Aware (NASDAQ:AWRE)
- Dolby Laboratories: Weak Growth, But The Valuation Is Too Cheap
- Cognition Therapeutics Schedules a Type C Meeting with FDA to Align on Endpoints for Phase 3 Trial of Zervimesine (CT1812) in DLB
- Dolby Expands Meta Partnership With Atmos and Vision Across Devices
- Your Meta AI Glasses Are Getting a Dolby Upgrade
- Financial Analysis: Zscaler (NASDAQ:ZS) vs. Dolby Laboratories (NYSE:DLB)
- Dolby and Meta Expand Dolby Atmos and Dolby Vision Across Meta's Ecosystem
Your note
Sign in to keep a note on DLB — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| COULING JOHN D | Officer | Sale | Sep 30, 2026 | 166,803 |
| DOLBY DAVID | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Feb 2, 2026 | 92,718 |
| GOTCHER PETER C | Director | Stock Award(Grant) | Feb 2, 2026 | 44,641 |
| PARK ROBERT J. | Chief Financial Officer | Sale | May 11, 2026 | 81,490 |
| REVANKAR SHRIRAM | Officer | Sale | Aug 13, 2026 | 73,274 |
| SEGARS SIMON | Director | Stock Award(Grant) | Feb 2, 2026 | 47,150 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 11.24% | 6,676,885 | 414.13M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 8.33% | 4,950,702 | 307.07M | Jun 29, 2026 |
| Bank Of New York Mellon Corporation | 8.11% | 4,817,216 | 298.79M | Jun 29, 2026 |
| Morgan Stanley | 7.74% | 4,601,750 | 285.42M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.58% | 2,721,876 | 168.82M | Jun 29, 2026 |
| First Trust Advisors LP | 4.55% | 2,705,504 | 167.81M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Eaton Vance Growth Trust-Eaton Vance Atlanta Capital SMID-Cap Fund | 3.73% | 2,217,691 | 137.55M | Jun 29, 2026 |
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.56% | 2,114,326 | 131.14M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.23% | 1,921,198 | 119.16M | Jun 29, 2026 |
| VANGUARD WORLD FUND-Vanguard Information Technology Index Fund | 2.60% | 1,546,086 | 95.90M | Aug 30, 2026 |
| First TRT Exch-Trd Fd. VI-First TRT SMID Cap Rising Dividend Achievers | 2.59% | 1,538,407 | 95.42M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.33% | 1,384,564 | 85.88M | Jun 29, 2026 |